Company: ANIX
Filing Date: 2025-03-11
Form Type: 10-Q
Source: 0001493152-25-009854
Chunk: 14

Company: Anixa Biosciences Inc
Filing Date: 2025-03-11
Form: 10-Q
Item: Part I, Item 8
Chunk 14
---

following as of:

 SCHEDULE OF ACCRUED EXPENSES

    January 31,  
    October 31, 

    2025  
    2024 

    (in thousands) 
  
    Payroll and related expenses 
    $515  
    $1,126 
  
    Accrued royalty and contingent legal fees 
     626  
     626 
  
    Accrued other 
     222  
     194 
  
    Accrued expenses 
    $1,363  
    $1,946 

6. NET LOSS PER SHARE OF COMMON STOCK

Basic net loss per common share
(“Basic EPS”) is computed by dividing net loss by the weighted average number of common shares outstanding. Diluted net loss
per common share (“Diluted EPS”) is computed by dividing net loss by the weighted average number of common shares and dilutive
common share equivalents and convertible securities then outstanding. Diluted EPS for all periods presented is the same as Basic EPS,
as the inclusion of the effect of common share equivalents then outstanding would be anti-dilutive. For this reason, excluded from the
calculation of Diluted EPS for the three months ended January 31, 2025 and 2024, were stock options to purchase 13,488,062 and 12,497,094
shares, respectively, and warrants to purchase 300,000 and 300,000 shares, respectively.

7. EFFECT OF RECENTLY ADOPTED AND ISSUED PRONOUNCEMENTS

In November 2023, the FASB issued
Accounting Standards Update 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, to provide more disaggregated
expense information about a public entity’s reportable segments. The amendments in this update should be applied retrospectively
and are effective for fiscal years beginning after December 15, 2023, and interim periods beginning after December 15, 2024. We began
a detailed assessment of the impact that this guidance will have on our consolidated financial statements and related disclosures, and
our analysis is currently ongoing.

In December 2023, the FASB issued
Accounting Standards Update 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, to require disaggregated information
about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid